These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31784203)

  • 1. Added value of para-aortic surgical staging compared to
    De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
    Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
    Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Leray H; Gabiache E; Courbon F; Brenot-Rossi I; Colineaux H; Lepage B; Lambaudie E; Martinez A; Voglimacci M; Weyl A; Deslandres M; Ducassou A; Motton S; Vaysse C; Chantalat E
    J Nucl Med; 2020 Oct; 61(10):1442-1447. PubMed ID: 32034109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
    Perez-Medina T; Pereira A; Mucientes J; García-Espantaleón M; Jiménez JS; Calles L; Rodríguez B; Iglesias E
    Int J Gynecol Cancer; 2013 Jan; 23(1):170-5. PubMed ID: 23196756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interest of para-aortic lymphadenectomy for locally advanced cervical cancer in the era of PET scanning.
    Khebbeb S; Rathat G; Serrand C; Bourdon A; Ferrer C; Duraes M
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():234-239. PubMed ID: 35397374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric development and evaluation of
    Lucia F; Bourbonne V; Pleyers C; Dupré PF; Miranda O; Visvikis D; Pradier O; Abgral R; Mervoyer A; Classe JM; Rousseau C; Vos W; Hermesse J; Gennigens C; De Cuypere M; Kridelka F; Schick U; Hatt M; Hustinx R; Lovinfosse P
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2514-2528. PubMed ID: 36892667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (
    Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S
    Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
    Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
    J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
    Lin SY; Tsai CS; Chang YC; Ng KK; Chang TC; Kao WH; Lai CH; Hong JH
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):577-85. PubMed ID: 25936817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
    Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
    Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
    Moore KN; Gold MA; McMeekin DS; Walker JL; Rutledge T; Zorn KK
    Gynecol Oncol; 2008 Mar; 108(3):466-71. PubMed ID: 18191994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
    Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
    Thelissen AAB; Jürgenliemk-Schulz IM; van der Leij F; Peters M; Gerestein CG; Zweemer RP; van Rossum PSN
    Gynecol Oncol; 2022 Mar; 164(3):667-674. PubMed ID: 34969533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.
    Frumovitz M; Ramirez PT; Macapinlac HA; Klopp AH; Nick AM; Ramondetta LM; Jhingran A
    Int J Gynecol Cancer; 2012 Sep; 22(7):1203-7. PubMed ID: 22810967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.